After finishing at $3.73 in the prior trading day, Surgepays Inc (NASDAQ: SURG) closed at $3.85, up 3.22%. In other words, the price has increased by $+0.1200 from its previous closing price. On the day, 608690 shares were traded.
Ratios:
Our goal is to gain a better understanding of SURG by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 5.08 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 7.42. For the most recent quarter (mrq), Quick Ratio is recorded 1.91 and its Current Ratio is at 2.63. In the meantime, Its Debt-to-Equity ratio is 0.19 whereas as Long-Term Debt/Eq ratio is at 0.03.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 15 ’23 when Cox Kevin Brian bought 5,200 shares for $4.72 per share. The transaction valued at 24,544 led to the insider holds 4,507,894 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SURG now has a Market Capitalization of 74.24M and an Enterprise Value of 65.06M. As of this moment, Surgepays’s Price-to-Earnings (P/E) ratio for their current fiscal year is 2.74. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.54 while its Price-to-Book (P/B) ratio in mrq is 1.96. Its current Enterprise Value per Revenue stands at 0.47 whereas that against EBITDA is 3.24.
Stock Price History:
Over the past 52 weeks, SURG has reached a high of $9.23, while it has fallen to a 52-week low of $3.65. The 50-Day Moving Average of the stock is 6.5814, while the 200-Day Moving Average is calculated to be 5.8260.
Shares Statistics:
The stock has traded on average 885.27K shares per day over the past 3-months and 769.5k shares per day over the last 10 days, according to various share statistics. A total of 14.40M shares are outstanding, with a floating share count of 12.95M. Insiders hold about 32.88% of the company’s shares, while institutions hold 7.05% stake in the company. Shares short for SURG as of Mar 15, 2024 were 1.67M with a Short Ratio of 1.88, compared to 1.98M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 8.65% and a Short% of Float of 12.23%.
Earnings Estimates
Its stock is currently analyzed by 1 different market analysts. On average, analysts expect EPS of $0.29 for the current quarter, with a high estimate of $0.29 and a low estimate of $0.29, while EPS last year was $0.31. The consensus estimate for the next quarter is $0.24, with high estimates of $0.24 and low estimates of $0.24.
Analysts are recommending an EPS of between $1 and $1 for the fiscal current year, implying an average EPS of $1. EPS for the following year is $0, with 0 analysts recommending between $0 and $0.
Revenue Estimates
1 analysts predict $32.32M in revenue for the current quarter. It ranges from a high estimate of $32.32M to a low estimate of $32.32M. As of the current estimate, Surgepays Inc’s year-ago sales were $36.5M, an estimated decrease of -11.50% from the year-ago figure. For the next quarter, 1 analysts are estimating revenue of $32.32M, a decrease of -17.20% less than the figure of -$11.50% in the same quarter last year. There is a high estimate of $32.32M for the next quarter, whereas the lowest estimate is $32.32M.
A total of 1 analysts have provided revenue estimates for SURG’s current fiscal year. The highest revenue estimate was $129.28M, while the lowest revenue estimate was $129.28M, resulting in an average revenue estimate of $129.28M. In the same quarter a year ago, actual revenue was $137.14M, down -5.70% from the average estimate.
